Home > Boards > US OTC > Biotechs > International Stem Cell Corp. (ISCO)

The posted PR is unrelated to ISCO.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
KarinCA Member Profile
Member Level 
Followed By 541
Posts 24,585
Boards Moderated 2
Alias Born 11/16/07
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 8/27/2019 6:01:43 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 8/14/2019 5:07:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/30/2019 3:44:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/7/2019 2:56:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/5/2019 1:48:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/5/2019 1:47:51 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2019 4:05:35 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/30/2019 6:31:48 AM
International Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson's Disease Clinical Trial InvestorsHub NewsWire - 4/29/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/23/2019 4:33:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/22/2019 2:13:50 PM
International Stem Cell Corporation Announces 2018 Fourth Quarter and Year-End Results InvestorsHub NewsWire - 4/16/2019 8:30:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 4/15/2019 6:13:56 AM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 4/1/2019 4:32:13 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 3/7/2019 6:05:53 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2019 4:42:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2019 4:42:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2019 4:41:47 PM
International Stem Cell Corporation Publishes Successful Results in Traumatic Brain Injury InvestorsHub NewsWire - 2/13/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/23/2019 4:27:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/22/2019 6:16:40 PM
International Stem Cell Corporation Granted Key US Patent Protecting Anti-Aging Business InvestorsHub NewsWire - 1/15/2019 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/6/2018 8:04:03 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/6/2018 8:01:22 AM
International Stem Cell Corporation is Valued at $6.16 per Share by Edison Investment Research InvestorsHub NewsWire - 12/5/2018 8:30:00 AM
KarinCA Member Level  Tuesday, 06/04/19 05:33:55 PM
Re: 236T568 post# 6527
Post # of 6561 
The posted PR is unrelated to ISCO.
The stem cells used are unrelated to the type ISCO uses.
The procedure is unrelated to the procedure used in ISCO clinical trial.

All the way around, the company in the posted pr and ISCO are unrelated. But, most importantly, unrelated in type of stem cells used.







To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist